This proof-of-concept in a human cerebral organoid model completes the pre-clinical studies to advance to clinical trials using the AAV9-GLB1 vector.doi:10.1016/j.ymgmr.2019.100513Yvonne L LatourRobin YoonSarah E ThomasChristina GrantCynthia J Tifft...